58502-29-7 Usage
Uses
Used in Pharmaceutical Industry:
1H-1,2,4-TRIAZOLE-3-METHANAMINE is used as a reactant for the preparation of peptidomimetics. These peptidomimetics act as granzyme B inhibitors, which are crucial in the treatment of autoimmune, inflammatory, and related diseases. By inhibiting granzyme B, a key mediator in the immune system, these peptidomimetics can help regulate immune responses and alleviate the symptoms of various conditions.
Check Digit Verification of cas no
The CAS Registry Mumber 58502-29-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,8,5,0 and 2 respectively; the second part has 2 digits, 2 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 58502-29:
(7*5)+(6*8)+(5*5)+(4*0)+(3*2)+(2*2)+(1*9)=127
127 % 10 = 7
So 58502-29-7 is a valid CAS Registry Number.
InChI:InChI=1/C3H6N4/c4-1-3-5-2-6-7-3/h2H,1,4H2,(H,5,6,7)
58502-29-7Relevant academic research and scientific papers
FUSED TRI-CYCLIC COMPOUND AS PDE3/PDE4 DUAL INHIBITOR
-
Paragraph 0137; 0140, (2021/05/20)
Provided is a fused tri-cyclic compound as PDE3/PDE4 dual inhibitor, and a use thereof in the preparation of drugs for PDE3/PDE4 associated diseases, particularly in medicinal functions such as chronic obstructive pulmonary disease (COPD). Provided are sp
